Vamorolone Suppliers & Bulk Manufacturers
Available Forms: Oral suspension
Available Strengths: 40 mg/mL
Reference Brands: Agamree (USA/EU)
Category:
Immune Disorder
Vamorolone is a corticosteroid medication used primarily for the treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and older. It helps reduce inflammation and slow muscle degeneration with fewer side effects compared to traditional steroids. Available as an oral suspension (40 mg/mL), Agamree works by modulating the immune response and inflammation in the body. It is a brand name; no generic versions are currently available.
vamorolone is available in Oral suspension
and strengths such as 40 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, vamorolone is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
vamorolone can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing